肺服欣乾粉吸入劑50微克/250微克

Država: Tajvan

Jezik: kitajščina

Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Navodilo za uporabo Navodilo za uporabo (PIL)
04-09-2021
Javno poročilo o oceni Javno poročilo o oceni (PAR)
10-04-2020

Aktivna sestavina:

SALMETEROL XINAFOATE;;FLUTICASONE PROPIONATE

Dostopno od:

台灣諾華股份有限公司 台北市中山區民生東路三段2號8樓 (01516589)

Koda artikla:

R03AK06

Farmacevtska oblika:

乾粉吸入劑

Sestava:

SALMETEROL XINAFOATE (1216002910) MG; FLUTICASONE PROPIONATE (8406002210) MG

Enote v paketu:

塑膠殼裝

Razred:

製 劑

Tip zastaranja:

須由醫師處方使用

Izdeluje:

AEROPHARM GMBH FRANCOIS-MITTERRAND-ALLEE 1,07407 RUDOLSTADT, GERMANY DE

Terapevtsko območje:

salmeterol and fluticasone

Terapevtske indikacije:

Salmeterol (as xinafoate) 50 mcg/fluticasone propionate 250 mcg適用於可逆性呼吸道阻塞疾病(ROAD)之常規治療,包括適合使用支氣管擴張劑及皮質類固醇組合療法之患有氣喘的兒童與成人。這可能包括:正在使用長效乙型作用劑(β-AGONIST)及吸入型皮質類固醇之有效維持劑量的患者。正在接受吸入型皮質類固醇療法,而仍有症狀之患者。接受支氣管擴張劑之常規治療,而需要吸入型皮質類固醇之患者。Salmeterol (as xinafoate) 50 mcg/fluticasone propionate 250 mcg適用於嚴重慢性阻塞性肺部疾病(FEV1<50%預期值,FEV1/FVC<70%)之維持治療,包括慢性支氣管炎和肺氣腫。

Povzetek izdelek:

註銷日期: 2020/09/07; 註銷理由: 自請註銷; 有效日期: 2021/05/17; 英文品名: AIRFLUSAL/device FORSPIRO 50mcg/250mcg

Status dovoljenje:

已註銷

Datum dovoljenje:

2016-05-17

Navodilo za uporabo

                                LAYOUT MANAGEMENT
Editor: Michael Müller
Version: 10.06.2015
Material No.:
46163206
Product:
LF AirFluSal Sdz. TW
Country:
Taiwan
Material:
leaflet
Dimensions / Size:
160 x 560 mm (end-folded 160 x 35 mm)
Data-Matrix-Code:
46163206
DESCRIPTION
COLOR SEPARATION
NON-PRINTING COLORS
remarks info
CORRECTION PROCESS
1.
2.
3.
4.
5.
6.
Date:
Date:
Date:
Date:
46163206
60
50 mcg salmeterol (as
xinafoate)250 mcg fluticasone propionate
Salmeterol (as xinafoate) 50 mcg/fluticasone propionate
250 mcg
(ROAD)
●
(β-agonist)
●
●
Salmeterol (as xinafoate) 50 mcg/fluticasone propionate
250 mcg(FEV
1
<50%
FEV
1
/FVC<70%)
Salmeterol (as xinafoate) 50 mcg/fluticasone propionate
250 mcg
salmeterol
(as xinafoate) 50 mcg/fluticasone propionate 250 mcg
salmeterol (as xinafoate) 50 mcg/fluticasone propionate
250 mcg
(
-REVERSIBLE OBSTRUCTIVE
AIRWAYS DISEASE, ROAD)
salmeterol (as xinafoate) 50 mcg/fluticasone
propionate 250 mcg
fluticasone
propionate
salmeterol (as xinafoate) 50 mcg/
fluticasone propionate 250 mcg
(50 mcg salmeterol
250
mcg fluticasone propionate)
(50 mcg salmeterol
100 mcg
fluticasone propionate)
salmeterol (as xinafoate)
50 mcg/fluticasone propionate 250 mcg
(COPD)
(50 mcg
salmeterol250 mcg fluticasone propionate)
salmeterol (as xinafoate) 50 mcg/fluticasone propionate
250 mcg
Salmeterol xinafoate/fluticasone propionate
()
Salmeterol xinafoate/fluticasone propionate
(salbutamol)
salmeterol xinafoate/fluticasone
propionate
salmeterol
xinafoate/fluticasone propionate
(COPD)
(COPD)salmeterol
xinafoate/fluticasone propionate
()
(COPD)
salmeterol xinafoate/
fluticasone propionate
salmeterol xinafoate/
fluticasone propionate
salmeterol xinafoate/fluticasone propionate
salmeterol xinafoate/fluticasone propionate
()
(
)
fluticasone propionate
fluticasone propionate
()
salmeterol xinafoate/fluticasone propionate
fluticasone propionate
ritonavir
fluticasone propionate
ritonavir
()
(SMART)
SEREVENT
(salmeterol xinafoate/fluticasone propionate)
SEREVENT
SEREVENT
SMART
()
ketoconazole
SEREVENT
QTc
CYP3A4
(
ketoconazole)
SEREV
                                
                                Preberite celoten dokument